FOLH1 and prostate carcinoma: The in vitro binding of PSMA-targeting ligands to mouse kidney cells was reported to be at least two-fold greater than binding to human kidney cells [53], suggesting that rapid kidney clearance in pre-clinical mouse models of prostate cancer is not an essential requirement.